StonvexLoading…
StonvexStonvexStonvexCore line items from RCMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q2 2026 2026-04-04 | Annual 2026 2026-01-03 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $83.04M | $319.40M | $232.93M | $162.64M |
Operating Income | $5.94M | $25.09M | $17.12M | $13.18M |
Net Income | $3.84M | $16.33M | $10.23M | $3.79M |
EPS (Diluted) | $0.52 | $2.14 | $1.34 | $1.04 |
Total Assets | $135.33M | $134.40M | $129.81M | $135.59M |
Total Liabilities | $91.04M | $88.42M | $88.44M | $97.80M |
Cash & Equivalents | $2.62M | $2.92M | $1.31M | $5.47M |
Free Cash Flow OCF − CapEx | $2.57M | $17.37M | $6.12M | $7.88M |
Shares Outstanding | 7.02M | 7.35M | 7.41M | 7.39M |